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Abstract: 
 
Periodontitis is an infectious disease that results in the destruction of the structures that support  the 
teeth, namely, alveolar bone and connective tissue attachment to teeth. It is initiated by pathogenic 
bacteria, which trigger an inflammatory response that is effective in preventing significant microbial 
colonization of the gingival tissues. In some individuals, the reaction to bacteria may lead to an 
excessive host response, resulting in periodontal tissue destruction. 
 
Cytokines play an important role in the pathology associated with chronic inflammatory diseases. 
The cytokines which are molecularly and chemically well defined are called interleukin and different 
interleukins play a significant role in the pathogenesis of periodontitis. In this review article the 
specific  roles of different interleukins are hereby explained.  
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INTRODUCTION: 
Cytokines are special type of messenger 
molecules that take message fromone area to 
other and modulate their function in 
inflammation and immunological function.1  
 
These are low-molecular weight proteins 
involved in the initiation and effector stages of 
immunity and inflammation, in which they 
regulate the amplitude and duration of the 
response. In other words, Cytokines are cell 
regulators that have a major influence on the 
production and activation of different effector 
cells.3 since they appear at various stages of 
inflammation, hence act as biomarkers. 
 
A) Cells producing cytokines: 
1) Leukocytes 
2) endothelial cells 
3) epithelial cells 
4) connective tissue cells 
5) pathological cells 
6) T cells  
7)  Macrophages4 
 
Included in the group of cytokines are 
interleukins, interferons, growth factors, and 
colony stimulating factors, various activating 
and inhibitory factors. These cytokines plays 
an important role in numerous biological 
activities including proliferation, 
development, differentiation, homeostasis, 
regeneration, repair and inflammation.5 
 
B) Nature of Cytokines(Figure 1 )6: 
1. Autocrine 
2. Paracrine 
3. Endocrine 
 
Interleukins:   The cytokines which are 
molecularly and chemically well defined are   
called interleukin.7 
 
Lymphokines: Cytokines produced by 
lymphocytes. 
Monokines:      Cytokines produced by 
monocyte and macrophage system. 
 
C) PROPERTIES OF CYTOKINES: 
1.  Pleotrophic: Act on more than one cell   
type. eg.: IL:4 
2. Redundancy: More than one cytokine 
can do the same thing.eg: IL-2, IL-4, IL-5 
3. Synergy: Two or more cytokines 
cooperate to produce an effect that 
different or greater than the combined 
effect of the two cytokines when 
functioning separately. eg: IL-4, IL-5 
induces class switch to IgE. 
4. Antagonist: Two or more cytokines work 
against each other. Eg: IFN-Y blocks class 
switch to IgE induced by IL-4.8
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D) 1) Classification by Jan Lindhe:9 
   
Proinflammatory cytokines: E.g IL-1 IL-6 
and TNF 
 
Chemotactic cytokines: E.g IL-8  
 
Lymphocytes signaling cytokines: E.g 
Cytokines released by TH1: IL-2, IFN. 
                                                                 
Cytokines released by TH2: IL-4, IL-5, IL-10 
and IL-13. 
 
2) Classification based on inflammatory 
action:10 
 
 Chemotactic : IL-8, MIP-1, MCP-1, RANTES 
 Pro-inflammatory : IL-1α, IL-1β, TNF-α, IL-6 
 Anti-inflammatory :  IL-1Ra, IL-4, IL-10 
Growth factor :  PDGF, EGF, FGF, IGF, 
VEGF    
Immunoregulatory :  IFN-γ, IL-2,4,5,7 
 
E) i) INTERLEUKIN-1:11 
It is a proinflammatory cytokine that has a 
large array of biological activities and   
directly regulates several genes expressed 
during inflammation.  
Source:   
Macrophages, monocytes, lymphocytes, 
osteoblast and fibroblast. 
 
Some of the structural features and biological 
activities of IL-1 relevant to periodontal 
disease include the following: 
1. Modifies endothelial lining: IL1/TNF act 
over the endothelial lining of the blood vessel 
and cause contraction and retraction of the 
endothelial cells, thus increasing inter 
endothelial gaps. Lymphocytes come out as 
inflammatory infiltrate. 
 
2. Express selectins, integrins and other 
adhesion molecules on fibroblasts, 
endothelial cells and immunocytes - 
lymphocytes, neutrophils, and monocytes.    
 
These adhesion molecules permit 
immunocytes to attach to and then migrate 
through the endothelial wall of the 
vasculature to enable chemotaxis to the site of 
infectious challenge. It also creates homing 
receptors for lymphocytes and monocytes to 
enable these cells to attach directly to 
connective tissue cells and thereby become 
a resident cell as part of an inflammatory. 
 
3. Stimulating endothelial cells and 
macrophage to produce chemokines that    
contributes to the diapedesis, chemotaxis 
and the recruitment of     leukocytes [Figure 
2].  
 
IL1/TNF act over the endothelial cell, send 
signals to the cytoplasm of endothelial cell 
then to nucleus to synthesize new proteins. 
 
The new protein formed is IL-8 which is also a 
chemokine. 
 
4.   Act on liver to produce C- reactive 
proteins which acts as a biomarker during 
inflammation. Other proteins released are 
fibrinogen, haptoglobin, alpha-1 antitrypsin 
and ceruloplasmin. 
 
 
5. In the bone marrow it increases levels of 
preformed neutrophils: so that more number 
of leukocyte arrive at the site of inflammation. 
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6.  IL-1/TNF act as pyrogens and stimulate 
the hypothalamus to produce fever and this is 
the reason fever occurs in inflammation. 
 
7. IL-lα andIL-lß are potent stimulators of 
connective tissue catabolism. These 
molecules stimulate bone resorption directly 
and trigger the release of large amounts of 
PGE2 from fibroblasts and monocytes. PGE2, 
in turn, is a moderately potent stimulator of 
vasodilation, edema and bone resorption. 
  
IL-1 also stimulates the secretion of matrix 
metalloproteinases (MMPs), which serve to 
degrade the extracellular matrix. 
      
8. IL-1 activates immunocytes, IL-1 
upregulates  the  expression of MHC proteins 
to facilitate antigen presentation and 
activation of T and B-cells. It promotes B-cell     
activation, proliferation, clonal expansion, 
and antibody secretion. 
 
 It serves to  "prime" phagocytic monocytes 
and neutrophils by up-regulating receptors 
for  complement and immunoglobulin. 
 
9. IL-1 is autostimulatory  in that it triggers 
the release of IL-1 from many other cells to 
amplify the IL-1 signal. The activity of IL- 1 is 
suppressed and controlled by the release of 
a specific inhibitor protein which serves as an 
IL-1 receptor antagonist (IL-ra), it binds and 
occupies the IL-1 receptor, but does not 
activate the cell. IL-Ira synthesis can be 
triggered by steroids and anti-inflammatory 
cytokines, such as IL-4 and IL-10. 
 
10.Bacterial  immunosuppressive factors, 
such as that produced by Prevotella 
intermedia and short chain fatty acids such as 
butyric and proprionic acid  inhibit IL-1 
production and there by inhibit lymphocytic 
proliferation. Other bacterial factors, such as 
the A. actinomycetemcomitans capsular 
polysacharride, trigger IL-1 release (as well 
as PGE2) and thereby elicit osteoclast 
formation and bone resortion in organ 
culture. 
 
11. Stimulate the T-helper cell to produce IL-
2 which further causes proliferation of T-
helper cells for both humoral and cell  
 
mediated immunity. 
12. Stimulates epithelial cells to proliferate    
and produce collagen: With regard to  
homeostasis of  Periodontal tissue, stimulation 
of the proliferation of          keratinocytes, 
fibroblasts and endothelial cells is  important.  
Furthermore, interleukin- 1 enhances 
fibroblast synthesis of type I procollagen,  
collagenase, hyaluronic acid, fibronectin and 
prostaglandin E. 
 
ii) Interleukin – 2(Figure 3)12 
 IL-2 is an autocrine and paracrine growth 
factor secreted by activated T lymphocytes 
and is essential for clonal T-cell proliferation. 
iii) Interleukin-3 (Previously known as 
multispecific hemopoietin) 
Sources: IL-3 is made primarily by T-
lymphocytes. 
Functions: 
  IL-3 supports the growth of multilineage  
bone marrow stem cells. 
 
 Interleukin-3 stimulates the growth 
precursors of all the hemopoietic lineages 
(red cells, granulocytes, macrophages and 
probably lymphocytes). 
    A minor population of T cells (CD4 CD8,   
with the cx43 TCR) also grows in response     
    to IL-3.13 
 
iv) Interleukin-4 (Previously known as B 
cell activating or differentiating factor-1 
Sources: 
 IL-4 is produced mainly by TH2 cells and 
mast cells 
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Functions [Figure 4]: 
 IL-4 acts on B cells to induce activation  and 
differentiation, leading in particular to the 
production of IgG1 and IgE. 
 It also acts on T cells as a growth and 
activation factor and promotes TH2 cell 
differentiation. 
 On macrophages, it induces MHC class II 
expression. 
 IL-4 is a major stimulus for production of 
IgE and the development of TH2 cells for 
defense against helminths and 
arthropods. It also antagonizes the effects 
of IF-γ and thus inhibits cell-mediated 
immunity 
 It inhibits production of pro-inflammatory 
cytokines such as IL-1 and TNF-α. 
 Excess IL-4 plays a part in allergic disease, 
causing high IgE production.14 
 
 
V) Interleukin-5 (also referred to as 
‘Eosinophil differentiation factor’ - 
EDF) 
Source: 
 IL-5 is produced mainly by TH2 cells. 
Functions [Figure 5]: 
 IL-5 is a growth and activating factor for 
eosinophils as a defense against helminths 
and arthropods. 
 It also stimulates the proliferation and 
differentiation of antigen-activated B-
lymphocytes and the production of IgA. 
 It is responsible for eosinophilia of 
parasitic diseases.15 
Interleukin-616 
Sources: 
The main sources of in vivo IL-6 are 
stimulated monocytes, fibroblasts, and 
endothelial cells, macrophages, T & B-cells  
 
and keratinocytes. IL-6 release can be 
elicited by lipopolysaccharides, IL-1, TNF-α,  
progesterone and estrogen can diminish its 
synthesis. 
Functions: 
 It acts on most cells, but is particularly 
important in inducing B cell to differentiate 
into antibody-forming cells (AFCs). One of 
the major functions of IL-6 is the induction 
of the final maturation of B-cells into 
immunoglobulin-secreting plasma cells. It 
stimulates the secretion of antibodies to 
such a degree that serum IgG1 levels can 
rise120-400-fold. 
 Stimulates the proliferation of B-
lymphocytes 
 Increases neutrophil production. 
 In the liver it stimulates the production of 
acute phase proteins    
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 IL-6 is considered to be an important 
growth factor for multiple myeloma 
malignancy of plasma cells. 
 
The interleukin-6 molecule, in contrast to 
most cytokines, contains a signal domain  
 
which makes the cells release interleukin-6 in 
large amounts, and interleukin-6 can act as an 
endocrine cytokine stimulating acute-phase 
response proteins in the liver and  in the 
thermoregulatory  center in the 
hypothalamus. 
 
Interleukin-7 (initially described as a pre-
B -cell growth factor)17 
Interleukin-7 was initially thought to be made 
by bone marrow stroma. IL-7 made by 
thymic stroma and acts on thymocytes. 
Sources: 
IL-7 is also produced by fibroblasts and bone 
marrow stromal cells. 
Functions: 
 It is a T-cell growth and activation factor. 
 It is a macrophage activation factor. 
 IL-7 plays a role in the survival and 
proliferation of immature B-lymphocytes 
and T-lymphocyte precursors.  
 
Interleukin-818: The potential role of IL-8 in 
periodontal diseases has been reviewed by 
Bickel. IL-8 is a member of the chemokine 
family which is a series of structurally related, 
small molecular weight peptides which have 
4 cysteine residues linked by disulfide 
bridges. 
 
 
 
 
Sources: 
They are produced by most cells of the body,  
especially macrophages and endothelial    
cells, and are involved in inflammation and 
cell migration. 
Functions: 
 IL-8 in particular is a powerful inducer of 
neutrophil chemotaxis. 
 The related RANTES induces chemotaxis 
of memory T cells and monocytes. 
 
Interleukin -917 
Sources: 
Interleukin-9 is secreted by some cultured T-
cells and has a growth promoting effects on 
several hemopoietic cell types. 
Functions: 
 In conjunction with IL-2, IL-3, IL-4 and 
erythropoietin, it may enhance 
hemopoiesis in vivo. 
 It may facilitate bone marrow derived 
mast cell growth stimulated by IL-3 and 
fetal thymocyte growth in response to IL-2.
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Interleukin-10 (also known as cytokine 
synthesis inhibitory factor)17 
IL-10 is an inhibitor of activated macrophages 
and dendritic cells and as such, regulates 
innate immunity and cell-mediated 
immunity. IL-10 inhibits their production of IL-
12, co-stimulator molecules, and MHC-II 
molecules, all of which are needed for cell-
mediated immunity [Figure 7]. 
 
 
 
 
Sources: 
IL-10 is produced mainly by macrophages 
and TH2 cells. 
Functions of IL-10: 
 IL-10 strongly inhibits the production of IL-
1α, IL-1β, IL-6, IL-8, IL-10 itself, IL-12, GM-
CSF, G-CSF, M-CSF, TNF-α, IFN-γ 
 It  inhibits antigen presentation and 
macrophage production of IL-I, IL-6 and 
TNF-α 
 It is important in B-cell activation
Interleukin-11 
Sources: 
Interleukin-l1 is derived from bone marrow. 
Functions: 
 It induces IL-6 dependent murine 
plasmacytoma cells to proliferate. 
 It may be important in the formation of 
platelets.17 
 
Interleukin-12(Figure 8) 
Interleukin-l2 acts in contrasting way to IL-β, 
in that it favors TH1 type response with 
macrophage and NK cells activation and 
induces IFN production. 
Sources: 
It is produced mainly by macrophages and 
dendritic cells. 
Functions:  
 Stimulate the synthesis of interferon-
gamma by T-lymphocytes and NK cells. 
 It is also an inducer of cell-mediated 
immunity. 
 Increases the killing activity of CTLs and 
NK cells. 
 IL-12 is a primary mediator of early innate 
immune responses to intracellular 
microbes.12
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Interleukin- 13 
Interleukin- 13 has structural and functional 
similarities to IL-4. It is an important mediator 
of allergic inflammation and disease. It is 
encoded by the IL13 gene. 
Sources: 
 IL-13 is cytokine secreted by many cell 
types, but especially T helper type 2 (TH2) 
cells. 
 Functions: 
 IL-13 increases the production of IgE by B-
lymphocytes, inhibits macrophages, and 
increases mucus production.  
 It promotes B-cell division. 
 It is a potent modulator of human 
monocyte and B-cell function. 
 It acts as a co-stimulatory signal for human   
B cells. 
 IL-13 specifically induces physiological 
changes in parasitized organs that are 
required to expel the offending organisms 
or their products. For example, expulsion 
from the gut of a variety of mouse 
helminths  requires IL-13 secreted by TH2 
cells.18 
 
Interleukin-14 (previously known as High-
molecular weight B cell growth factor) 
Functions: 
 It predominantly acts to enhance the 
proliferation of B-cells and to induce 
memory B-cell production and 
maintenance. 
 Inhibits immunoglobulin secretion.12 
 Interleukin-15 
It shares many biological properties of IL-2 
Sources: 
IL-15 is produced by various cells including 
macrophages. 
Functions: 
 IL-15 stimulates NK cell proliferation and 
proliferation of T-lymphocytes.  
 Interleukin- 15 is a T-cell growth factor.12 
 
 Interleukin-16 (previously called 
lymphocyte chemoattractant factor-LCF) 
It recruits and activates many other cells 
expressing the CD4 molecule, including 
monocytes, eosinophils, and dendritic cells. 
Sources:  
Variety of cells (including lymphocytes and 
some epithelial cells). 
Functions: 
 Interleukin-16 is also known as 
‘Lymphocyte chemo attractant’. 
 It induces IL-2 receptor expression by T-
lymphocytes. 
 Chemoattractant for certain immune cells 
expressing the cell surface molecule 
CD4.12
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 Interleukin-17 
Interleukin-17 (IL-17) is a proinflammatory 
cytokine derived from T cells. 
Sources: 
Produced mainly by cells of the Th1/Th0 
phenotype (CD4+ T cells) but not cells of the 
Th2 phenotype. Recent findings have defined 
IL-17-producing cells as a new Th cell 
lineage; renamed Th17. Th17 cells are highly 
proinflammatory and can mediate 
autoimmune diseases. 
Induction: 
It is proposed that induction of Th17 
responses requires three distinct steps: 
induction, amplification and stabilization, 
whereby TGF- β plus IL-6 induce 
differentiation of Th17 cells, IL-21 amplifies 
the frequency of Th17 cells, and IL-23 
stabilizes the phenotype of previously 
differentiated Th17 cells.   
 
Loss of any of one of the members in this 
pathway (IL-21 or IL-23) severely limits the 
Th17 response.  IL-17 has been shown to 
stimulate epithelial, endothelial and 
fibroblastic cells to produce IL-6, IL-8, and 
PGE2.  In addition, IL-17 induces receptor 
activator of nuclear factor kappa B ligand 
(RANKL) production by osteoblasts. 
Functions: 
 lnterleukin -l7 may be an initiator of T-cell-
dependent inflammatory reactions and 
part of the cytokine network linking the 
immune system to hematopoiesis.  
 Enhances cytokine secretion. 
 Members of the IL-17 and -17R families 
are unique in amino acid sequence, with 
little homology to other cytokine classes. 
Thus, few predictions about their function 
could be made simply on the basis of 
sequence similarities with other 
molecules.19 
 
Interleukin-18 
Sources:  
Keratinocytes, macrophages. 
Functions: 
 IL-18 stimulates the production of 
interferon-γ by NK cells and T-
lymphocytes and thus induces cell-
mediated immunity.  
 Acts on T cells, B cells, NK cells. 
 It up-regulates IFN-γ production, 
enhanced NK cell cytotoxicity.20 
Interleukin-27 is a novel member of the 
interleukin- 6 ⁄ interleukin-12 family of 
cytokines, which consist of a heterodimer of 
interleukin-12 p40-related protein and 
interleukin-12 p35-related protein p28. 
Interleukin-27 has many effects on immune 
and nonimmune cells, including the 
differentiation of T helper cells.  
 
 When osteoclast formation was induced by 
macrophage colony-stimulating factor ⁄ 
RANKL, co-treatment with interleukin-27 
resulted in partial inhibition of 
osteoclastogenesis. The importance of 
interleukin- 27 as a regulator of osteoclast 
formation must await confirmation by other 
groups and elucidation of the molecular 
mechanisms.21 
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